These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10368810)

  • 21. Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside.
    Rickard SE; Yuan YV; Thompson LU
    Cancer Lett; 2000 Dec; 161(1):47-55. PubMed ID: 11078912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics of purified flaxseed and associated mammalian lignans in male Wistar rats.
    Mukker JK; Singh RS; Muir AD; Krol ES; Alcorn J
    Br J Nutr; 2015 Mar; 113(5):749-57. PubMed ID: 25716060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure to flaxseed or purified lignan during lactation influences rat mammary gland structures.
    Ward WE; Jiang FO; Thompson LU
    Nutr Cancer; 2000; 37(2):187-92. PubMed ID: 11142092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lignans in homemade and commercial products containing flaxseed.
    Nesbitt PD; Thompson LU
    Nutr Cancer; 1997; 29(3):222-7. PubMed ID: 9457743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemopreventive effects of dietary flaxseed on colon tumor development.
    Bommareddy A; Arasada BL; Mathees DP; Dwivedi C
    Nutr Cancer; 2006; 54(2):216-22. PubMed ID: 16898866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.
    Saggar JK; Chen J; Corey P; Thompson LU
    Mol Nutr Food Res; 2010 Mar; 54(3):415-25. PubMed ID: 19904759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in ApcMin mice.
    van Kranen HJ; Mortensen A; Sørensen IK; van den Berg-Wijnands J; Beems R; Nurmi T; Adlercreutz H; van Kreijl CF
    Nutr Cancer; 2003; 45(2):203-10. PubMed ID: 12881015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flaxseed and its mammalian lignan precursor cause a lengthening or cessation of estrous cycling in rats.
    Orcheson LJ; Rickard SE; Seidl MM; Thompson LU
    Cancer Lett; 1998 Mar; 125(1-2):69-76. PubMed ID: 9566698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumorigenic effect of a mammalian lignan precursor from flaxseed.
    Thompson LU; Seidl MM; Rickard SE; Orcheson LJ; Fong HH
    Nutr Cancer; 1996; 26(2):159-65. PubMed ID: 8875553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No effect on adenoma formation in Min mice after moderate amount of flaxseed.
    Oikarinen S; Heinonen SM; Nurmi T; Adlercreutz H; Mutanen M
    Eur J Nutr; 2005 Aug; 44(5):273-80. PubMed ID: 15278371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone.
    Kitts DD; Yuan YV; Wijewickreme AN; Thompson LU
    Mol Cell Biochem; 1999 Dec; 202(1-2):91-100. PubMed ID: 10705999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women.
    Hutchins AM; Martini MC; Olson BA; Thomas W; Slavin JL
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1113-8. PubMed ID: 11045796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in anticancer lignan levels in flaxseed.
    Thompson LU; Rickard SE; Cheung F; Kenaschuk EO; Obermeyer WR
    Nutr Cancer; 1997; 27(1):26-30. PubMed ID: 8970178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and stereochemical characterization of lignans in flaxseed and pumpkin seeds.
    Sicilia T; Niemeyer HB; Honig DM; Metzler M
    J Agric Food Chem; 2003 Feb; 51(5):1181-8. PubMed ID: 12590454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial beta-glucuronidase activity in F344 rats.
    Reddy BS; Mangat S; Weisburger JH; Wynder EL
    Cancer Res; 1977 Oct; 37(10):3533-6. PubMed ID: 908005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of flaxseed lignan and oil on bone health of breast-tumor-bearing mice treated with or without tamoxifen.
    Chen J; Saggar JK; Ward WE; Thompson LU
    J Toxicol Environ Health A; 2011; 74(12):757-68. PubMed ID: 21541878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ruminal metabolism of flaxseed ( Linum usitatissimum) lignans to the mammalian lignan enterolactone and its concentration in ruminal fluid, plasma, urine and milk of dairy cows.
    Gagnon N; Côrtes C; da Silva D; Kazama R; Benchaar C; dos Santos G; Zeoula L; Petit HV
    Br J Nutr; 2009 Oct; 102(7):1015-23. PubMed ID: 19393113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men.
    Fukumitsu S; Aida K; Shimizu H; Toyoda K
    Nutr Res; 2010 Jul; 30(7):441-6. PubMed ID: 20797475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human metabolism of mammalian lignan precursors in raw and processed flaxseed.
    Nesbitt PD; Lam Y; Thompson LU
    Am J Clin Nutr; 1999 Mar; 69(3):549-55. PubMed ID: 10075344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioaccessibility of lignans from flaxseed (Linum usitatissimum L.) determined by single-batch in vitro simulation of the digestive process.
    Fuentealba C; Figuerola F; Estévez AM; Bastías JM; Muñoz O
    J Sci Food Agric; 2014 Jul; 94(9):1729-38. PubMed ID: 24243589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.